Sale!

Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel for Acute Leukemia T, B, or Myeloid Test

Original price was: $450.Current price is: $312.

-31%

The Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel is a sophisticated diagnostic tool that identifies and classifies acute leukemia subtypes through advanced cellular analysis. This test precisely characterizes leukemia cells by detecting specific surface markers on T-cells, B-cells, or myeloid cells, enabling accurate diagnosis and proper treatment planning. Using cutting-edge flow cytometry technology, the panel provides detailed information about cell lineage, maturation stage, and abnormal antigen expression patterns. Patients experiencing unexplained fatigue, frequent infections, easy bruising, or abnormal blood counts should consider this test. The comprehensive analysis helps oncologists determine the exact leukemia subtype, which is crucial for selecting targeted therapies and predicting treatment outcomes. Available for only $312 USD, this same-day testing service provides rapid results to support timely medical decisions and personalized treatment strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel for Acute Leukemia T, B, or Myeloid Test

Comprehensive Introduction to Leukemia Immunophenotyping

Immunophenotyping by Flow Cytometry represents a cornerstone in modern hematological diagnostics, providing essential information for accurate leukemia classification and treatment planning. This advanced diagnostic panel utilizes sophisticated flow cytometry technology to analyze cell surface markers, enabling precise identification of leukemia subtypes including T-cell, B-cell, or myeloid lineages. The test’s importance cannot be overstated, as proper leukemia classification directly influences treatment selection, prognosis assessment, and therapeutic monitoring.

What the Test Measures and Detects

This comprehensive diagnostic panel measures specific cellular markers through advanced flow cytometry analysis:

  • Lineage-Specific Markers: Identifies T-cell (CD3, CD4, CD8), B-cell (CD19, CD20), and myeloid (CD13, CD33, CD117) antigens
  • Maturation Markers: Assesses cell development stages and abnormal maturation patterns
  • Abnormal Antigen Expression: Detects aberrant marker combinations not found in normal cells
  • Blast Cell Characterization: Precisely identifies and quantifies immature blast cells
  • Immunological Profiles: Creates comprehensive cellular fingerprints for accurate classification

Who Should Consider This Test

This diagnostic panel is essential for individuals presenting with concerning symptoms or laboratory findings:

  • Patients with unexplained fatigue, weakness, or persistent fever
  • Individuals experiencing frequent infections or unusual bleeding
  • Those with abnormal complete blood count (CBC) results showing elevated white blood cells
  • Patients with enlarged lymph nodes, spleen, or liver without clear cause
  • Individuals with bone pain, night sweats, or unexplained weight loss
  • Patients with abnormal peripheral blood smears suggesting leukemia

Significant Benefits of Immunophenotyping Testing

Choosing this advanced diagnostic approach offers multiple advantages:

  • Accurate Diagnosis: Provides definitive leukemia classification essential for proper treatment
  • Treatment Guidance: Helps oncologists select targeted therapies based on cell lineage
  • Prognostic Information: Offers insights into disease behavior and expected outcomes
  • Minimal Residual Disease Monitoring: Enables detection of low-level disease after treatment
  • Rapid Results: Same-day reporting supports timely medical decisions
  • Comprehensive Analysis: Multiple marker assessment ensures thorough evaluation

Understanding Your Test Results

Your immunophenotyping results will provide detailed information about leukemia cell characteristics:

  • Lineage Assignment: Clear identification of T-cell, B-cell, or myeloid leukemia
  • Maturation Stage: Information about cell development and abnormal patterns
  • Marker Expression: Specific antigen profiles that guide treatment selection
  • Blast Percentage: Quantification of immature cells in the sample
  • Clinical Correlation: Results interpreted in context of your complete clinical picture

Your hematologist or oncologist will explain the significance of your specific results and discuss appropriate treatment options based on the findings.

Test Pricing and Availability

Test Description Price (USD)
Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Discount Price: $312
Regular Price: $450

Convenient Testing Locations Across USA

We have established branches in all major cities throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our nationwide network ensures accessible testing services with consistent quality standards and rapid turnaround times.

Take Action for Your Health Today

Don’t delay in obtaining the critical diagnostic information you need for proper leukemia management. Our same-day testing service provides rapid results to support your healthcare team’s treatment decisions. Contact us now to schedule your immunophenotyping test and take the first step toward accurate diagnosis and targeted treatment.

Call or WhatsApp: +1(267) 388-9828 to book your test appointment today!

Sample Requirements and Processing

Turnaround Time: Sample Daily by 9 am; Report Same Day

Sample Type: 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear

Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE

Important Note: Clinical history is mandatory for proper test interpretation